课题基金 / 基金详情

Molecular mechanisms of host cell escape by Mycobacterium tuberculosis

Molecular mechanisms of host cell escape by Mycobacterium tuberculosis
结核分枝杆菌逃逸宿主细胞的分子机制
批准号:
10322367
负责人:
VOLKER BRIKEN
金额:
$61.58万
依托单位国家:
美国
项目类别:
财政年份:
2019
资助国家:
美国
项目状态:
已结题
起止时间:
2019-01-10 至 2023-12-31

项目摘要

项目成果

VOLKER BRIKEN的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Abstract Mycobacterium tuberculosis (Mtb) causes pulmonary tuberculosis (TB) in humans. In 2015 alone,10.4 million new cases were reported, leading to approximately 1.4 million deaths. There are no effective vaccines for TB and only sub-optimal chemotherapeutics exist. Mtb, after a period of intracellular replication and inhibition of host cell apoptosis, leaves the phagosome and triggers cell lysis in order to exit the host cell. There is a gap in our understanding of how Mtb exploits host cell signaling in order to mediate these events. We have discovered a novel transcriptional repressor, Rv3167c, that is important for suppression of phagosomal escape, host cell necrosis and of macroautophagy (autophagy) induction. This activity is mediated via suppression of gene transcription of genes encoding for synthesis and transport of the outer cell membrane lipid phthiocerol dimycocerosates (PDIM). In the current application we propose to utilize a unique set of Mtb mutants discovered in our lab to elucidate the molecular mechanisms of Mtb-mediated host cell necrosis induction. In AIM1 we will characterize the host cell necrosis and autophagy signaling pathways engaged after phagosomal exit of Mtb. AIM1.1. will test how Mtb mediates the regulation of the host kinase AKT. The Aims 1.2 and 1.3 will explore cell signaling events downstream of AKT leading to necrosis or autophagy induction, respectively. These approaches will be used to identify central signaling hubs within the signaling network that will be most interesting for host directed therapeutic approaches. In AIM2 we will characterize the relevance of host cell escape pathway for virulence of Mtb and its potential as a target for therapeutic approaches. In Aim 2.1, knock-out or knock-in mice will be used to corroborate the ex vivo findings of the importance of select host cell signaling proteins during in vivo infection. In Aim 2.2 our discovery of host cell necrosis signaling components will be exploited to test their relevance for Mtb virulence during aerosol infection of mice and thus determine their potential as novel candidates for host-targeted therapeutics using the mouse model of tuberculosis. We believe that our findings will have great translational potential since inhibition of Mtb-mediated necrosis should reduce virulence of the bacteria and decrease host lung pathology.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Manipulation of the host cell inflammasome by Mycobacterium tuberculosis
  • 批准号:
    10619641
  • 项目类别:
  • 资助金额:
    $58.52万
  • 财政年份:
    2021
  • 负责人:
    VOLKER BRIKEN
  • 依托单位:
Manipulation of the host cell inflammasome by Mycobacterium tuberculosis
  • 批准号:
    10296451
  • 项目类别:
  • 资助金额:
    $62.98万
  • 财政年份:
    2021
  • 负责人:
    VOLKER BRIKEN
  • 依托单位:
Manipulation of the host cell inflammasome by Mycobacterium tuberculosis
  • 批准号:
    10424569
  • 项目类别:
  • 资助金额:
    $59.9万
  • 财政年份:
    2021
  • 负责人:
    VOLKER BRIKEN
  • 依托单位:
Identification of Mycobacterium tuberculosis genes that mediate inhibition of the host cell IFN-beta signaling
  • 批准号:
    9901025
  • 项目类别:
  • 资助金额:
    $22.78万
  • 财政年份:
    2020
  • 负责人:
    VOLKER BRIKEN
  • 依托单位:
海外基金